United States · Exchanges & live quotes · Nasdaq

Commit To Buy Capricor Therapeutics At $3, Earn 69.5% Annualized Using Options

Published by Nasdaq · United States 1 h ago

Investors considering a purchase of Capricor Therapeutics Inc (Symbol: CAPR) shares, but cautious about paying the going market price of $6.33/share, might benefit from…

Read the full article on Nasdaq Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)

Also worth reading

OilPrice.com

Oil Traders Brace for a Wild Week as Brent Approaches $120

Investopedia

California Is One of the Most Expensive States for the American Dream. Here’s What It Costs

CoinMarketCap

PAX Gold Sees 3.14% Move Amid Gold Correction, Hacks

Cboe Global Markets

Week of 10/26/2026: Tech Risk Premium Rising Ahead of Key Earnings

Google Finance